PortfoliosLab logo
MCK vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MCK and LLY is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

MCK vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in McKesson Corporation (MCK) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MCK:

1.05

LLY:

-0.29

Sortino Ratio

MCK:

1.50

LLY:

-0.14

Omega Ratio

MCK:

1.25

LLY:

0.98

Calmar Ratio

MCK:

1.26

LLY:

-0.42

Martin Ratio

MCK:

3.11

LLY:

-0.79

Ulcer Index

MCK:

9.73%

LLY:

13.27%

Daily Std Dev

MCK:

27.77%

LLY:

38.40%

Max Drawdown

MCK:

-82.83%

LLY:

-68.27%

Current Drawdown

MCK:

-1.42%

LLY:

-25.25%

Fundamentals

Market Cap

MCK:

$89.51B

LLY:

$640.72B

EPS

MCK:

$25.71

LLY:

$12.28

PE Ratio

MCK:

27.85

LLY:

58.12

PEG Ratio

MCK:

1.14

LLY:

1.09

PS Ratio

MCK:

0.25

LLY:

13.08

PB Ratio

MCK:

5.04

LLY:

40.64

Total Revenue (TTM)

MCK:

$359.05B

LLY:

$49.00B

Gross Profit (TTM)

MCK:

$13.13B

LLY:

$40.03B

EBITDA (TTM)

MCK:

$5.13B

LLY:

$16.27B

Returns By Period

In the year-to-date period, MCK achieves a 25.79% return, which is significantly higher than LLY's -7.20% return. Over the past 10 years, MCK has underperformed LLY with an annualized return of 12.53%, while LLY has yielded a comparatively higher 27.66% annualized return.


MCK

YTD

25.79%

1M

3.03%

6M

16.37%

1Y

28.30%

3Y*

30.31%

5Y*

37.75%

10Y*

12.53%

LLY

YTD

-7.20%

1M

-19.15%

6M

-5.11%

1Y

-11.00%

3Y*

33.78%

5Y*

38.01%

10Y*

27.66%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


McKesson Corporation

Eli Lilly and Company

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

MCK vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MCK
The Risk-Adjusted Performance Rank of MCK is 8282
Overall Rank
The Sharpe Ratio Rank of MCK is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of MCK is 7878
Sortino Ratio Rank
The Omega Ratio Rank of MCK is 8383
Omega Ratio Rank
The Calmar Ratio Rank of MCK is 8787
Calmar Ratio Rank
The Martin Ratio Rank of MCK is 8080
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 3232
Overall Rank
The Sharpe Ratio Rank of LLY is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 3333
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 3333
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 2525
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MCK vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for McKesson Corporation (MCK) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MCK Sharpe Ratio is 1.05, which is higher than the LLY Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of MCK and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

MCK vs. LLY - Dividend Comparison

MCK's dividend yield for the trailing twelve months is around 0.38%, less than LLY's 0.78% yield.


TTM20242023202220212020201920182017201620152014
MCK
McKesson Corporation
0.38%0.47%0.50%0.54%0.72%0.95%1.16%1.32%0.80%0.80%0.53%0.46%
LLY
Eli Lilly and Company
0.78%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

MCK vs. LLY - Drawdown Comparison

The maximum MCK drawdown since its inception was -82.83%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for MCK and LLY.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

MCK vs. LLY - Volatility Comparison

The current volatility for McKesson Corporation (MCK) is 7.22%, while Eli Lilly and Company (LLY) has a volatility of 16.83%. This indicates that MCK experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MCK vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between McKesson Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20212022202320242025
90.82B
12.73B
(MCK) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

MCK vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between McKesson Corporation and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20212022202320242025
4.0%
82.5%
(MCK) Gross Margin
(LLY) Gross Margin
MCK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, McKesson Corporation reported a gross profit of 3.64B and revenue of 90.82B. Therefore, the gross margin over that period was 4.0%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

MCK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, McKesson Corporation reported an operating income of 1.59B and revenue of 90.82B, resulting in an operating margin of 1.8%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

MCK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, McKesson Corporation reported a net income of 1.26B and revenue of 90.82B, resulting in a net margin of 1.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.